Anti-human IL-2Ra / CD25 (Basiliximab Biosimilar) MBL2D patent Anti-ANGPTL4 Formulation 100 mM

patent Anti-ANGPTL4 Formulation 100 mM Pro-Ac 20mM Arg pH 5

Citation example: “Human tissue sections using Human Cytochrome C IHC Kit (IHC0117H

PIK3C3 phosphorylates phosphatidylinositol (PI) to produce phosphatidylinositol 3-phosphate [PI(3)P]

and growth and neurotrophic factors

it activates the Wnt signaling pathway in a DVL1-dependent manner by negatively regulating the GSK3B phosphotransferase activity

Anti-human IL-2Ra / CD25 (Basiliximab Biosimilar) MBL2D patent Anti-ANGPTL4 Formulation 100 mMApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name IL 2Ra CD25 Target Uniprot P01589 Overview Catalog# BIO0117SM Product Name Anti human IL 2Ra CD25 (Basiliximab Biosimilar) Specifications Conjugation None Clone# Basiliximab Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with sterile ddH2O